These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23782249)

  • 21. Identifying cancer mutations as therapeutic targets.
    Azvolinsky A
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25122735
    [No Abstract]   [Full Text] [Related]  

  • 22. Stakeholder research on biospecimen needs and reactions to the development of a national cancer human biobank by the National Cancer Institute.
    Myles R; Massett HA; Comey G; Atkinson N; Allsop D; Compton C
    J Natl Cancer Inst Monogr; 2011; 2011(42):16-23. PubMed ID: 21672891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development.
    Poste G; Carbone DP; Parkinson DR; Verweij J; Hewitt SM; Jessup JM
    Clin Cancer Res; 2012 Mar; 18(6):1515-23. PubMed ID: 22422403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prototypical process for creating evidentiary standards for biomarkers and diagnostics.
    Altar CA; Amakye D; Bounos D; Bloom J; Clack G; Dean R; Devanarayan V; Fu D; Furlong S; Hinman L; Girman C; Lathia C; Lesko L; Madani S; Mayne J; Meyer J; Raunig D; Sager P; Williams SA; Wong P; Zerba K
    Clin Pharmacol Ther; 2008 Feb; 83(2):368-71. PubMed ID: 18091762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NCI Alliance for Nanotechnology in Cancer: achievement and path forward.
    Ptak K; Farrell D; Panaro NJ; Grodzinski P; Barker AD
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):450-60. PubMed ID: 20552623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging as a Biomarker: Standards for Change Measurements in Therapy workshop summary.
    Clarke LP; Sriram RD; Schilling LB
    Acad Radiol; 2008 Apr; 15(4):501-30. PubMed ID: 18389935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the need for a standardized cancer HUman Biobank (caHUB): findings from a national survey with cancer researchers.
    Massett HA; Atkinson NL; Weber D; Myles R; Ryan C; Grady M; Compton C
    J Natl Cancer Inst Monogr; 2011; 2011(42):8-15. PubMed ID: 21672890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers.
    Kamat AM; Hegarty PK; Gee JR; Clark PE; Svatek RS; Hegarty N; Shariat SF; Xylinas E; Schmitz-Dräger BJ; Lotan Y; Jenkins LC; Droller M; van Rhijn BW; Karakiewicz PI;
    Eur Urol; 2013 Jan; 63(1):4-15. PubMed ID: 23083902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A national cancer clinical trials system for targeted therapies.
    Mendelsohn J
    Sci Transl Med; 2011 Mar; 3(75):75cm8. PubMed ID: 21430266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.
    Rodriguez H; Tezak Z; Mesri M; Carr SA; Liebler DC; Fisher SJ; Tempst P; Hiltke T; Kessler LG; Kinsinger CR; Philip R; Ransohoff DF; Skates SJ; Regnier FE; Anderson NL; Mansfield E;
    Clin Chem; 2010 Feb; 56(2):237-43. PubMed ID: 20007859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
    Dancey JE; Dobbin KK; Groshen S; Jessup JM; Hruszkewycz AH; Koehler M; Parchment R; Ratain MJ; Shankar LK; Stadler WM; True LD; Gravell A; Grever MR;
    Clin Cancer Res; 2010 Mar; 16(6):1745-55. PubMed ID: 20215558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving cancer research. Leaders cite collaboration and increased areas of study as ways to fight the disease.
    Printz C
    Cancer; 2013 May; 119(10):1765-6. PubMed ID: 23649487
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular diagnostics of lung cancers at the Brigham and Women's Hospital and Dana-Farber Cancer Institute: technology in rapid evolution.
    Lindeman N
    Arch Pathol Lab Med; 2012 Oct; 136(10):1198-200. PubMed ID: 23020723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular diagnostics in pathology].
    Stenzinger A; Penzel R; Endris V; Weichert W
    Dtsch Med Wochenschr; 2013 May; 138(20):1061-8. PubMed ID: 23670263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.
    Badr HA; Alsadek DM; Darwish AA; Elsayed AI; Bekmanov BO; Khussainova EM; Zhang X; Cho WC; Djansugurova LB; Li CZ
    Expert Rev Proteomics; 2014 Apr; 11(2):227-36. PubMed ID: 24611567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summary of the National Institute of Standards and Technology and US Food And Drug Administration cell counting workshop: Sharing practices in cell counting measurements.
    Lin-Gibson S; Sarkar S; Elliott JT
    Cytotherapy; 2018 Jun; 20(6):785-795. PubMed ID: 29699860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncology biomarkers: discovery, validation, and clinical use.
    Heckman-Stoddard BM
    Semin Oncol Nurs; 2012 May; 28(2):93-8. PubMed ID: 22542316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bridging the gap: moving predictive and prognostic assays from research to clinical use.
    Williams PM; Lively TG; Jessup JM; Conley BA
    Clin Cancer Res; 2012 Mar; 18(6):1531-9. PubMed ID: 22422405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Special report: multiple molecular testing of cancers to identify targeted therapies.
    BlueCross BlueShield Association
    Technol Eval Cent Assess Program Exec Summ; 2013 Jun; 28(1):1-2. PubMed ID: 23865106
    [No Abstract]   [Full Text] [Related]  

  • 40. Institutional profile: Developing and evaluating new drugs for cancer treatment: perspectives from the US National Cancer Institute.
    Trimble EL; Abrams JS; Ansher SS; Smith MA; Zwiebel JA; Tomaszewski JE
    Future Med Chem; 2010 Apr; 2(4):555-9. PubMed ID: 21426005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.